172 related articles for article (PubMed ID: 8547083)
1. Diagnosis of transfusion-associated graft-versus-host disease by polymerase chain reaction in fludarabine-treated B-chronic lymphocytic leukaemia.
Briz M; Cabrera R; Sanjuán I; Forés R; Díez JL; Herrero M; Regidor C; Algora M; Fernández MN
Br J Haematol; 1995 Oct; 91(2):409-11. PubMed ID: 8547083
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia.
Maung ZT; Wood AC; Jackson GH; Turner GE; Appleton AL; Hamilton PJ
Br J Haematol; 1994 Nov; 88(3):649-52. PubMed ID: 7819085
[TBL] [Abstract][Full Text] [Related]
3. Transfusion-associated graft-versus-host disease (TA-GVHD) in fludarabine-treated patients: is it time to irradiate blood component?
Briones J; Pereira A; Alcorta I
Br J Haematol; 1996 Jun; 93(3):739-41. PubMed ID: 8652406
[No Abstract] [Full Text] [Related]
4. Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease.
Khouri IF; Przepiorka D; van Besien K; O'Brien S; Palmer JL; Lerner S; Mehra RC; Vriesendorp HM; Andersson BS; Giralt S; Körbling M; Keating MJ; Champlin RE
Br J Haematol; 1997 May; 97(2):466-73. PubMed ID: 9163617
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.
Hutchinson K; Kopko PM; Muto KN; Tuscano J; O'Donnell RT; Holland PV; Richman C; Paglieroni TG; Wun T
Transfusion; 2002 Dec; 42(12):1567-72. PubMed ID: 12473136
[TBL] [Abstract][Full Text] [Related]
6. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine treatment and transfusion-associated graft-versus-host disease.
Williamson LM; Wimperis JZ; Wood ME; Woodcock B
Lancet; 1996 Aug; 348(9025):472-3. PubMed ID: 8709796
[No Abstract] [Full Text] [Related]
8. Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience.
Montserrat E; Lopez-Lorenzo JL; Manso F; Martin A; Prieto E; Arias-Sampedro J; Fernandez MN; Oyarzabal FJ; Odriozola J; Alcala A; Garcia-Conde J; Guardia R; Bosch F
Leuk Lymphoma; 1996 May; 21(5-6):467-72. PubMed ID: 9172812
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
Hocepied AM; Falkson CI; Falkson G
S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
[TBL] [Abstract][Full Text] [Related]
10. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine treatment and transfusion-associated graft-versus-host disease.
Saven A
Lancet; 1996 Aug; 348(9025):473. PubMed ID: 8709797
[No Abstract] [Full Text] [Related]
12. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
Myint H; Copplestone JA; Orchard J; Craig V; Curtis D; Prentice AG; Hamon MD; Oscier DG; Hamblin TJ
Br J Haematol; 1995 Oct; 91(2):341-4. PubMed ID: 8547072
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
Wells T; Kovacs MJ
Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
[TBL] [Abstract][Full Text] [Related]
16. [Experience with fludarabine treatment and review of the literature].
Telek B; Rejtó L; Kiss A; Batár P; Reményi G; Rák K; Udvardy M
Orv Hetil; 2002 Jun; 143(24):1459-65. PubMed ID: 12138643
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy.
Kiewe P; Seyfert S; Körper S; Rieger K; Thiel E; Knauf W
Leuk Lymphoma; 2003 Oct; 44(10):1815-8. PubMed ID: 14692540
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous resolution of transfusion-associated graft-versus-host disease.
Mori S; Matsushita H; Ozaki K; Ishida A; Tokuhira M; Nakajima H; Kizaki M; Sugiura H; Kikuchi A; Handa M
Transfusion; 1995 May; 35(5):431-5. PubMed ID: 7740616
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
Syed NN; Khurshid M
J Pak Med Assoc; 2006 Jan; 56(1):44-5. PubMed ID: 16454137
[TBL] [Abstract][Full Text] [Related]
20. Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay.
Bosanquet AG; Johnson SA; Richards SM
Br J Haematol; 1999 Jul; 106(1):71-7. PubMed ID: 10444165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
